Skip to main content
Benjamin R. Morehouse

Benjamin R. Morehouse

Assistant Professor, Department of Molecular Biology & Biochemistry, Charlie Dunlop School of Biological Sciences (Primary)

Assistant Professor, Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences (Secondary)

Biography

Benjamin R. Morehouse, Ph.D., is Assistant Professor in the Department of Molecular Biology & Biochemistry in the Charlie Dunlop School of Biological Sciences and the Department of Pharmaceutical Sciences in the School of Pharmacy and Pharmaceutical Sciences at the University of California, Irvine. His research focuses on nucleotide second messengers and chemical signals in innate immunity across evolution, examining how bacteria and animals use cyclic nucleotide signaling to defend against viral infection. Morehouse received a Ph.D. in Biochemistry and Biophysics from Brandeis University in 2017, where he studied the cyclization mechanism of limonene synthase, and completed postdoctoral training at Harvard Medical School and Dana-Farber Cancer Institute as a Ruth L. Kirschstein NRSA Fellow.

Morehouse has made contributions to understanding the evolutionary origins of immune signaling pathways, demonstrating that STING cyclic dinucleotide sensing originated in bacteria and characterizing diverse cyclic nucleotide signals in bacterial antiviral defense systems. His work has revealed structural mechanisms of immune surveillance proteins and identified how viruses subvert bacterial defense systems. He has published over 20 papers in journals including Nature, Cell, and Science, with several as first or co-corresponding author.

Morehouse received recognition by the Michelson Medical Research Foundation as of one of five 2026 Michelson Grants: Next Generation Prize winners to support his research in uncharacterized human immune genes. Morehouse received the Chancellor's Award for Distinguished Fostering of Undergraduate Research from UCI in 2025 and the Outstanding Postdoctoral Fellow Award from Harvard Medical School in 2021. He was awarded a Young Investigator Award at the 10th International Conference on cGMP in 2022 and received an NIH NIGMS Early Stage Investigator Maximizing Investigators' Research Award (MIRA) for 2025-2029. He serves on the Early-career Editorial Board of mBio Journal and is a member of the UCI Center for Virus Research and UCI Institute for Immunology.

Return to top

Education

  • B.S. in Biochemistry, Worcester Polytechnic Institute (WPI), 2012
  • Ph.D. in Biochemistry and Biophysics, Brandeis University, 2018
Return to top

Distinctions

  • 2026 Michelson Grants: Next Generation Prize, 2026
  • Chancellor's Award for Distinguished Fostering of Undergraduate Research, UCI, 2025
  • NIH NIGMS ESI MIRA 1R35GM157311-01, 2025-2029
  • Young Investigator Award, 10th International Conference on cGMP, 2022
  • HMS Outstanding Postdoctoral Fellow Award, Harvard Medical School, 2021
  • NIH F32 Individual Postdoctoral Fellowship (Ruth L. Kirschstein NRSA), 2019-2021
  • NIH T32 Training Grant, Cancer Immunology, Dana-Farber Cancer Institute, 2018-2019
  • SPROUT Virtual Incubator Innovation Award, Brandeis University, 2015-2016
  • NIH T32 Training Grant, Macromolecular Structure & Mechanism, Brandeis University, 2013-2014
Return to top

Areas of Expertise

  • Innate Immunity Signaling Pathways
  • Cyclic Nucleotide Second Messengers
  • Bacterial Antiphage Defense Mechanisms
  • Structural Biology Enzyme Characterization
  • CRISPR Polymerase Decoy Nucleotides
  • TIR-STING Filament Complex Formation
  • Pharmacological Cyclic Nucleotide Therapeutics

Recent Publications

Return to top

Contact Information

Website: https://faculty.sites.uci.edu/morehouselab/

Email: b.morehouse@uci.edu

Phone: (949) 824-4845

Address: 520A Steinhaus Hall, Irvine, CA 92697-3900

Return to top

This profile was created with the help of AI.

Last updated on 3/11/2026.